Skip to main content

Table 1 Baseline patient characteristics, overall and by ASPECTS determinations

From: Low (0–5) Alberta Stroke Program Early Computed Tomography Score on admission predictive of worse functional outcome after mechanical thrombectomy for anterior circulation large vessel occlusion

Characteristic

Patients, No. (%)

Overall (N = 343)

ASPECTS0–5 (n = 50)

ASPECTS 6–10 (n = 293)

P value

Age, y

63.6 ± 12.6

61.1 ± 11.0

64.1 ± 12.8

0.058

Female

104(30.3)

9(18)

95(32.4)

0.044a

Hypertension

198(57.7)

30(60)

168(57.3)

0.725

Diabetes mellitus

90(26.2)

11(22)

79(27)

0.410

Hyperlipidemia

104(30.3)

20(40)

84(28.7)

0.107

Atrial fibrillation/flutter

133(38.3)

20(40)

113(38.6)

0.848

Coronary artery disease

67(19.5)

8(16)

59(20.1)

0.495

Current/prior tobacco use

162(47.2)

27(54)

135(46.1)

0.300

Current/prior alcohol intake

167(48.7)

26(52)

141(48.1)

0.612

TOAST classification

   

0.678

 Large artery atherosclerosis

256(74.6)

36(72)

220(75.1)

 

 Cardioembolism

79(23)

12(24)

67(22.9)

 

 Other determined etiology

8(2.3)

2(4)

6(2)

 

 Prestroke

77(22.4)

11(22)

66(22.5)

0.934

 Baseline NIHSS

15.2 ± 4.5

18.1 ± 5.1

14.6 ± 4.3

 < 0.001a

 HMCAS

211(61.5)

39(78)

172(58)

0.010a

 Signs of early infarction

215(62.7)

45(90)

170(58)

 < 0.001a

 DBP on admission, mmHg

82.8 ± 15.1

82.4 ± 14.6

82.9 ± 15.2

0.999

 SBP on admission, mmHg

140.5 ± 25.1

135.1 ± 27.2

141.4 ± 24.5

0.052

 HbA1c, mmol/L

6.3(5.7–8.0)

6.7(5.7–8.0)

6.3(5.7–8.0)

0.354

 D-dimer, mmol/L

1.3(0.7–3.1)

1.7(0.9–3.8)

1.3(0.7–2.9)

0.192

Occlusive location

   

0.378

 ICA

91(26.5)

17(34)

74(25.3)

 

 MCA M1

150(43.7)

21(42)

129(44)

 

 MCA M2

22(6.4)

1(2)

21(7.2)

 

 ICA + MCA

80(23.3)

11(22)

69(23.5)

 

 IV tPA

82(23.9)

7(14)

75(25.6)

0.760

 Oneset to puncture, min

412.0(233.5–609.0)

422.5(280.7–545.5)

410.0(227.0–615.0)

0.918

 Device passes

1.5(1–2)

1.5(1–2)

1.5(1–2)

0.255

 Balloon-guided catheter

80(23.3)

10(20)

70(23.9)

0.548

 Angioplasty and stenting

26(7.6)

4(8)

22(7.5)

0.903

  1. Significant values in bold
  2. Data expressed as n (%) or mean ± standard devation values
  3. aASPECTS Alberta Stroke Program Early CT Score, TOAST Trial of Org 10172 in Acute Stroke Treatment, NIHSS National Institutes of Health Stroke Scale, HMCAS hyperdense middle cerebral artery sign, DBP diastolic blood pressure, SBP systolic blood pressure, HbA1c glycosylated hemoglobin, ICA internal carotid artery, MCA middle cerebral artery, IV tPA intravenous tissue plasminogen activator